Misuse of Drugs Act 1971

Part I E+W+S+N.I. Class A Drugs

1 The following substances and products, namely:— E+W+S+N.I.

Acetorphine.	Lysergamide.
[F1 Alfentanil.]	Lysergide and otherN-alkyl derivatives of lysergamide.
Allylprodine.	Mescaline.
Alphacetylmethadol.	Metazocine.
Alphameprodine.	Methadone.
Alphamethadol.	Methadyl acetate.
Alphaprodine.	Methyldesorphine.
Anileridine.	Methyldihydromorphine (6-methyldihydromorphine).
Benzethidine.	Metopon.
Benzylmorphine (3-benzylmorphine).	Morpheridine.
Betacetylmethadol.	Morphine.
Betameprodine.	Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.
Betamethadol.	Myrophine.
Betaprodine.	. . . F2
Bezitramide.	Nicomorphine (3,6-dinicotinoylmorphine).
Bufotenine.	Noracymethadol.
Cannabinol, except where contained in cannabis or cannabis resin.	Norlevorphanol.
Cannabinol derivatives.	Normethadone.
[F3 Carfentanil.]	Normorphine.
Clonitazene.	Norpipanone.
Coca leaf.	Opium, whether raw, prepared or medicinal.
Cocaine.	Oxycodone.
Desomorphine.	Oxymorphone.
Dextromoramide.	Pethidine.
Diamorphine.	Phenadoxone.
Diampromide.	Phenampromide.
Diethylthiambutene.	Phenazocine.
[F4 Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).]	[F5 Phencyclidine.]
DihydrocodeinoneO-carboxymethyloxime.	Phenomorphan.
Dihydromorphine.	Phenoperidine.
Dimenoxadole.	Piminodine.
Dimepheptanol.	Piritramide.
Dimethylthiambutene.	Poppy-straw and concentrate of poppy-straw.
Dioxaphetyl butyrate.	Proheptazine.
Diphenoxylate.	Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).
Dipipanone.	Psilocin.
[F6 Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]	Racemethorphan.
Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.	Racemoramide.
Ethylmethylthiambutene.	Racemorphan.
[F1 Eticyclidine.]	[F1 Rolicyclidine.]
Etonitazene.	[F7 Sufentanil.]
Etorphine.	[F1 Tenocylidine.]
Etoxeridine.	Thebacon.
[F8 Etryptamine]
Fentanyl.	Thebaine.
Furethidine.	[F7 Tilidate.]
Hydrocodone.	Trimeperidine.
Hydromorphinol.	[F9 4-Bromo-2,5-dimethoxy-a-methylphenethylamine].
Hydromorphone.	4-Cyano-2-dimethylamino-4,4-diphenylbutane.
Hydroxypethidine.	4-Cyano-1-methyl-4-phenyl-piperidine.
Isomethadone.	N,N-Diethyltryptamine.
Ketobemidone.	N,N-Dimethyltryptamine.
Levomethorphan.	2,5-Dimethoxy-a,4-dimethylphenethylamine.
Levomoramide.	[F10 N-Hydroxy-tenamphetamine.]
Levophenacylmorphan.	1-Methyl-4-phenylpiperidine-4-carboxylic acid.
Levorphanol.	2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.
[F3 Lofentanil]	[F11 4-Methyl-aminorex]
	4-Phenylpiperidine-4-carboxylic acid ethyl ester.

Annotations:

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F1 Word inserted by S.I. 1984/859, art. 2(2)

F2 Words repealed by S.I. 1973/771, art. 2

F3 Word inserted by S.I. 1986/2230, art. 2(2)(a)

F4 Word inserted by S.I. 1975/421, art. 3

F5 Word inserted by S.I. 1979/299, art. 2

F6 Word inserted by S.I. 1973/771, art. 2

F7 Word inserted by S.I. 1983/765, art. 2(a)

F8 Sch. 2 Pt. I para. 1(a): Word inserted (1.5.1998) by S.I. 1998/750, art.2(2)

F9 Words inserted by S.I. 1975/421, art. 3

F10 Word inserted by S.I. 1990/2589, art. 2(a)(i)

F11 Word inserted by S.I. 1990/2589, art. 2(a)(ii)

[F12 (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine anN-alkylphenethylamine,a-methylphenethylamine, anN-alkyl-a-methylphenethylamine,a-ethylphenethylamine, or anN-alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.]

[F13 (d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi) by replacement of the N-propionyl group by another acyl group;

(e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii) by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v) by formation of an N-oxide or of a quaternary base.]

Annotations:

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F1 Word inserted by S.I. 1984/859, art. 2(2)

F2 Words repealed by S.I. 1973/771, art. 2

F3 Word inserted by S.I. 1986/2230, art. 2(2)(a)

F4 Word inserted by S.I. 1975/421, art. 3

F5 Word inserted by S.I. 1979/299, art. 2

F6 Word inserted by S.I. 1973/771, art. 2

F7 Word inserted by S.I. 1983/765, art. 2(a)

F8 Sch. 2 Pt. I para. 1(a): Word inserted (1.5.1998) by S.I. 1998/750, art.2(2)

F9 Words inserted by S.I. 1975/421, art. 3

F10 Word inserted by S.I. 1990/2589, art. 2(a)(i)

F11 Word inserted by S.I. 1990/2589, art. 2(a)(ii)

F12 Sch. 2 para 1(b)(c) added by S.I. 1977/1243, art. 3(b)

F13 Sch. 2 para. 1(d)(e) added by S.I. 1986/2230, art. 2(2)(b)

2 Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan. E+W+S+N.I.

3 Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F14 not being a substance for the time being specified in Part II of this Schedule]. E+W+S+N.I.

Annotations:

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F14 Words inserted by S.I. 1973/771, art. 2

4 Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above. E+W+S+N.I.

5 Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above. E+W+S+N.I.

6 Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule. E+W+S+N.I.